Among the Center’s elaborate plan to distribute the vaccine against the coronavirus disease (Covid-19), are the country’s air and road transport network and the sites where the vaccine will be administered to eligible people in the first phase. On Friday, the subject matter expert committee (SEC) of the Central Medicines …
Read More »
The National Medicines Regulator’s Committee of Subject Matters (SEC) will meet again on Friday to make a decision on the Serum Institute of India (SII) Oxford-AstraZeneca’s Emergency Use Authorization Application (EUA) and Candidate Bharat Biotech vaccines against coronavirus disease. (COVID-19). The SEC had met for a second time on Wednesday …
Read More »
NEW DELHI: The drug regulator’s Subject Matter Expert Committee (SEC) on the Covid-19 vaccine sought more time to analyze updated data submitted by the Serum Institute of India and Bharat Biotech for emergency use authorization (USA ) for their respective SARS vaccine candidates. CoV2. The committee will meet again on …
Read More »
The American pharmaceutical company Pfizer Inc. said it has no data to establish that a single dose of its Covid-19 vaccine would provide protection against the virus after more than 21 days, undermining the observation of the Joint Committee on Vaccination and Immunization (JCVI) of the UK. The UK government …
Read More »
VG Somani, Comptroller General of Drugs of India (DCGI), in a webinar on Thursday indicated that India was close to approving a COVID-19 vaccine. Mr. Somani was participating in a webinar, organized by the Department of Biotechnology, in which vaccine experts, infectious disease experts and representatives of companies developing vaccines …
Read More »
India is likely to get a coronavirus disease (Covid-19) vaccine in the New Year, the country’s top drug regulator hinted during a webinar on the science behind the vaccine’s development that allowed it to arrive from the lab. to people in less than 12 months. “We will have a Happy …
Read More »
AstraZeneca Plc will soon publish data showing that the effectiveness of its covid-19 vaccine increases up to 95% if the two injections are separated by approximately 2-3 months, said Adar Poonawalla, executive director of the Serum Institute of India (SII), partner. manufacturing company British. “You will be getting good news …
Read More »
The nations of the European Union launched a coordinated effort on Sunday to administer the COVID-19 vaccine to the most vulnerable among the bloc’s nearly 450 million inhabitants, marking a moment of hope in the continent’s battle against the worst crisis in public health in a century. Healthcare workers, the …
Read More »
With preparations underway for a possible January launch of the vaccine, India’s drug regulator is looking into the UK, which sources say may give the Oxford Covid-19 vaccine its go-ahead next week, ahead of decide to grant emergency use authorization to the Serum Institute. who is manufacturing the shots here. …
Read More »
With preparations underway for a possible launch of the vaccine in January, India’s drug regulator is looking to the UK, which sources say may give Oxford its go-ahead. COVID-19 vaccine next week, before deciding to give emergency use authorization to the Serum Institute that makes the injections here. Once the …
Read More »